Trexquant Investment’s Cytek Biosciences CTKB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $153K | Sell |
45,131
-503,873
| -92% | -$1.71M | ﹤0.01% | 1461 |
|
2025
Q1 | $2.2M | Buy |
549,004
+306,405
| +126% | +$1.23M | 0.03% | 833 |
|
2024
Q4 | $1.57M | Buy |
242,599
+80,909
| +50% | +$525K | 0.02% | 952 |
|
2024
Q3 | $896K | Buy |
161,690
+23,296
| +17% | +$129K | 0.01% | 1084 |
|
2024
Q2 | $772K | Buy |
+138,394
| New | +$772K | 0.01% | 1090 |
|
2023
Q1 | – | Sell |
-72,179
| Closed | -$737K | – | 1489 |
|
2022
Q4 | $737K | Buy |
+72,179
| New | +$737K | 0.02% | 766 |
|
2022
Q3 | – | Sell |
-74,678
| Closed | -$801K | – | 1439 |
|
2022
Q2 | $801K | Buy |
74,678
+19,082
| +34% | +$205K | 0.04% | 614 |
|
2022
Q1 | $599K | Buy |
+55,596
| New | +$599K | 0.03% | 684 |
|